CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...